FDA Inspection 1053961 — Bruno Michon, M.D., Clinical Investigator
The FDA completed an inspection of Bruno Michon, M.D., Clinical Investigator on Apr 27, 2018 in Quebec. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Apr 27, 2018
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Quebec (Canada)
Additional Details
Clinical Investigator (CI)